Citigroup Inc Wave Life Sciences Ltd. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Citigroup Inc holds 69,006 shares of WVE stock, worth $984,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,006

Previous 27,463 151.27%

Holding current value

$984,715

Previous $137,000 312.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.12 - $9.01 $212,700 - $374,302	41,543 Added 151.27%	69,006 $565,000
Q2 2024 Aug 12, 2024	BUY	$4.38 - $6.48 $58,635 - $86,747	13,387 Added 95.11%	27,463 $137,000
Q1 2024 May 10, 2024	BUY	$3.54 - $6.84 $13,179 - $25,465	3,723 Added 35.96%	14,076 $86,000
Q4 2023 Feb 09, 2024	BUY	$4.16 - $6.87 $37,831 - $62,475	9,094 Added 722.32%	10,353 $52,000
Q3 2023 Nov 09, 2023	SELL	$3.56 - $5.75 $370,592 - $598,569	-104,099 Reduced 98.81%	1,259 $7,000
Q2 2023 Aug 10, 2023	SELL	$3.51 - $4.69 $168,093 - $224,604	-47,890 Reduced 31.25%	105,358 $383,000
Q1 2023 May 11, 2023	SELL	$3.58 - $6.3 $23,334 - $41,063	-6,518 Reduced 4.08%	153,248 $663,000
Q4 2022 Feb 09, 2023	BUY	$3.18 - $7.0 $477,343 - $1.05 Million	150,108 Added 1554.23%	159,766 $1.12 Million
Q3 2022 Nov 10, 2022	BUY	$2.37 - $4.28 $19,462 - $35,147	8,212 Added 567.91%	9,658 $35,000
Q2 2022 Aug 10, 2022	SELL	$1.23 - $3.25 $1,832 - $4,842	-1,490 Reduced 50.75%	1,446 $5,000
Q1 2022 May 12, 2022	SELL	$2.0 - $3.28 $22,894 - $37,546	-11,447 Reduced 79.59%	2,936 $6,000
Q4 2021 Feb 10, 2022	BUY	$3.14 - $5.15 $19,546 - $32,058	6,225 Added 76.31%	14,383 $45,000
Q3 2021 Nov 10, 2021	BUY	$4.89 - $7.12 $39,892 - $58,084	8,158 New	8,158 $40,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account